for inflammation, infections, viral
and immune diseases.
The body's way of
becoming cancer free
85% respond 15%
make full recoveries
Full recoveries
in 70% of cases
-
Select Gender View
-
Next Step
Terms of Use
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages.
Here is a time lapse video of the 8th assay we do in our laboratory - our GcMAF activates macrophages that eat cancers cells. We are probably the only people in the world with this technology.
Watch the video to see what happens to cancer cells when GcMAF is added without macrophages. This again is a world first, and again it has been done in our laboratory. Within just 4 weeks a research abstract paper on our results has already been accepted for publication at this year’s Immunology Conference in California.
Clinical Results and Treatment Strategies, Cambridge
American Journal of Immunology 10 (1): 23-32, 2014 The first paper on the results in our Treatment Centre…
Ours is selected as a Key Scientific Article
The article in “Nutrients” describing the product that we now call “Goleic”, and that already…
We discover the cause of autism in the brain
Our first stunning breakthrough research paper of 2014 was made available to the public on 2nd January…
Infiniti BioMed Pte Ltd is the exclusive distributor for the following nations:
Thailand, Singapore, Vietnam, Myanmar, Cambodia, Hong Kong, Macau, Japan, Taiwan and Sri Lanka.
French: www.firstimmune.fr
German: www.firstimmune.de
Italian: www.firstimmune.it
Greek: www.gcmaf.gr
Swedish: www.gcmaf.se
Spanish: www.gcmaf.es
Russian: www.gcmaf.ru
Polish: www.gcmaf.pl